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Gender Bias in Health Care: A Life or Death 
Issue for Women with Coronary Heart Disease 
Carol Jonann Bess· 
Introduction 
Growing evidence in medical research suggests a gender bias against 
women, particularly in the area of coronary heart disease (CHD). This 
disparity exists at all levels of health care delivery from office visits to in-
hospital care. Gender bias may result in delayed or inaccurate diagnosis, 
unequal medical interventions, and higher mortality for women who 
undergo invasive cardiac and surgical procedures.} While research 
conducted in other areas of medical care indicate a bias against women,2 
recent research in cardiac care presents the most worrisome evidence to 
date that women are dying because physicians fail to timely diagnose and 
treat CHD as aggressively as they do in men. 
Part I of this note explores early recognition of gender bias and 
research in the 1970s and early 1980s. During this period, researchers 
attempted to explain why gender bias exists. Today researchers remain 
unable to account for many inequities, but offer several theories to explain 
its existence. Part I examines the attitudes of health care providers, 
specifically as they relate to the gender of the patient in relation to the 
gender of the physician. Part I also examines the disproportionate effect 
of gender bias on older women. The male model of health care is offered 
as the vehicle of discrimination against women. 
Part IT examines gender bias in CHD, beginning with delayed or 
inaccurate diagnosis of angina (chest pain) associated with CHD. Further, 
this section examines why women are not offered early access to diagnostic 
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2. See Part I, infra. 
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procedures for CHD. When procedures are offered, the results may not 
have the same meaning for women as for men. Research suggests that 
women diagnosed with myocardial infarction have a higher mortality than 
men. Delayed access to interventions such as thrombolysis, angioplasty, 
and coronary artery bypass grafting results in higher mortality for women. 
Finally, extrapolation from all-male clinical testing of drugs results in 
different outcomes for women in the primary prevention of CHD. 
Part ill examines the legal ramifications of unequal care for women 
who have CHD and whether this violates the equal protection clause of the 
Fourteenth Amendment to the United States Constitution. Since almost 
every major hospital providing cardiac intervention and care in the United 
States receives federal and state funding via Medicare and Medicaid, these 
health providers may not discriminate in access to or provision of medical 
care. Gender bias against women may also violate other federal and state 
statutes. 
Part IV explores solutions to this gender bias. First, the National 
Institute of Health (NIH) must be forced to live up to their promise to 
increase funding for women's issues. In response to the U.S. Public Health 
Service's Task Force on Women's Health Issues in 1985,3 NIH promised 
to increase funding to study women's health issues.4 However, as of June 
1990, nearly three years after this promise, the General Accounting Office 
reported NIH had made very little progress toward this end.5 Second, 
medical schools should be encouraged to change the male-centered medical 
model to a male/female medical model. Finally, the American Medical 
Women's Association should continue to encourage the medical community 
to develop a women's specialty in medicine. Parting out women's health 
care between the family practitioner or internist and the obstetrician-
gynecologist may not provide comprehensive health care for women.· 
In conclusion, the "why" of gender discrimination is least important. 
Our priority in research should be to identify when it occurs, and take 
measures to see that it ceases. The Council on Ethical and Judicial Affairs 
of the American Medical Association reports, ''The medical community 
cannot tolerate any discrepancy in the provision of care that is not based 
on appropriate biological or medical indications.,,6 The long-term quality 
of life and health of women depend on finding a solution to this problem. 
3. Council on Ethical and Judicial Affairs, American Medical Association, Gender 
Disparites in Clinical Decison Making, 266 JAMA 559 (1991) (citing U.S. Public Health 
Service, Women's Health: Report of the Public Health Service Task Force on Women's 
Health Issues (1985». 
4. Id. (citing Hearings Before the House Energy and Commerce Subcommittee on Health 
and the Environment, WIst Cong., 1st Sess. (1990) (testimony of Mark V. Nadel, Associate 
Director, U.S. General Accounting Office». 
5. Council on Ethical and Judicial Affairs, supra note 3. 
6. [d. at 561. 
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I. The Scope of Gender Bias in Health Care 
A. A HISTORICAL PERSPECTIVE 
The roots of women's health issues arose from the Feminist Movement 
in the late 1970s and challenged the medical profession's authority over 
women's bodies.7 In the midst of the Women's Movement in the late 
1970s, women complained that their physical complaints were not 
considered by physicians as seriously as those of men. Armitage et ale 
were among the first researchers to examine this allegation. 8 Armitage's 
San Diego study suggested that men received more diagnostic services and 
more appropriate treatment for their complaints than did women.9 In 1981, 
Verbrugge and Steiner examined the same five medical complaints as 
Armitage and discovered that while women actually receive more medical 
care than men, there were statistically significant differences between the 
care delivered. 1O When the complaint is chest pain, a potentially more 
serious condition, physicians diagnosed men differently than women. 
Specifically, "Men's chest pain is due to circulatory conditions (heart 
disease) more often; and women's, to respiratory conditions (bronchitis and 
pleurisy).,,11 Verbrugge attributed the apparent contradiction in outcome 
from Armitage's research to the small sample in the San Diego study (n=40 
patients) as compared to hers (n=46,868 visits to physician). Current 
literature interprets Verbrugge's study as indicating a higher morbidity 
among women (more acute and chronic, non-lethal conditions leading to 
poor health) and higher mortality among men (conditions leading to 
death). 12 Rodin states, "Men are sick less often, but their illnesses and 
injuries are more severe; men have higher rates of chronic diseases that are 
the leading causes of death.,,13 
7. Karen Johnson & Laurel Dawson, Women's Health as a Multidisciplinary Specialty: 
An Exploratory Proposal, 45 J. AM. MEn. WOMEN'S ASSN. 222 (1990). 
8. Lois M. Verbrugge & Richard P. Steiner, Physician Treatment of Men and Women 
Patients: Sex Bias or Appropriate Care?, 19 MEo. CARE 609, 632 n.l (1981) (citing A. J. 
Annitage et al., Response of Physicians to Medical Complaints in Men and Women, 241 
JAMA 2186 (1979». 
9. Annitage, supra note 8, at 2190. 
10. Verbrugge, supra note 8, at 632 n.l. 
11. Id. at 628. The five complaints used in both studies were fatigue, headache, 
vertigo/dizziness, chest pain, and back pain. Other significant differences include: (1) men 
complaining of fatigue receive more drug prescriptions, (2) women complaining of headache 
receive more diagnostic services, (3) men complaining of dizziness/vertigo get more 
diagnostic work-up, but women get more return appointments, (4) women with back pain 
receive more diagnostic, therapeutic, and follow-up care. Id. at 629. 
12. Judith Rodin & Jeannette R. Ickovics, Women's Health: Review and Research Agenda 
As We Approach the 21st Century, 45 AM. PSYCHOL. 1018, 1021 (1990). 
13. Id. at 1021 (citing Verbrugge, infra note 19). 
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B. CULTURAL BIASES AGAINST WOMEN RESULT IN GENDER BIAS IN 
HEALTH CARE 
Researchers proposed several theories to explain the existence of gender 
bias in health care. In 1975, Nathanson synthesized research concerning 
sex differences in morbidity and utilization of physical and mental health 
services. 14 She employed three explanatory models previously proposed 
in research: "( 1) women report more illness than men because it is 
culturally more acceptable for them to be ill - 'the ethic of health is 
masculine'; (2) the sick role is relatively compatible with women's other 
role responsibilities, and incompatible with those of men; and (3) women's 
assigned social roles are more stressful than those of men; consequently, 
they have more illness."15 Nathanson observed these studies did not 
differentiate between illness and illness behavior and concluded there was 
insufficient data using these three explanatory models to link women's 
higher morbidity and lower mortality to various dimensions of the feminine 
role. 16 Marcus and Seeman further examined the feminine role and illness 
and concluded inflexible role obligations contribute to differences between 
men and women in reporting illness; but when this variable was controlled, 
women reported more chronic conditions than men. l7 
In 1982, Cleary et al. studied both illness and illness behavior of men 
and women and concluded "the consistency of sex differences found using 
different types of indicators and different types of data supports the notion 
14. Constance A. Nathanson, Illness and the Feminine Role: A Theoretical Review. 9 
Soc. SCI. & MED. 57 (1975). 
15. [d. at 59. See also Council on Judicial and Ethical Mfairs, supra note 3 (citing the 
following studies: W. R. Gove & J. Tudor, Adult Sex Roles and Mental Illness. 78 AM. J. 
SOCIOL. 812 (1973) (concluding more women than men are mentally ill and women have 
more transient situational personality disorders and psychosomatic disorders); D. L. Philips 
& B. E. Segal, Sexual Status and Psychiatric Symptoms. 34 AM. SOCIOL. REv. 58 (1969) 
(concluding women report more symptoms because illness is stigmatizing for men, less so 
for women); K. Broverman et al., Sex-Role Stereotypes and Clinical Judgments of Mental 
Health. 34 J. CONSULT. CUN. PSYCHOL. 1 (1970) (concluding concepts of mental health 
held by health professionals differed depending upon the sex of the patient); W. A. GLASER, 
SOCIAL SETTINGS AND MEDICAL ORGANIZATION (1970) (concluding the sick role is more 
compatible with a woman's role); C. Smith-Rosenberg & C. Rosenberg, The Female 
Animal: Medical and Biological Views of Woman and Her Role in 19th Century America, 
60 J. AM. RIST. 332 (1973) (concluding woman's health is dictated by her reproductive 
system and disorders of this system may appear in remote areas of her body. Men suffer no 
parallel disability). 
16. Nathanson, supra note 14, at 61. 
17. Alfred C. Marcus & Teresa E. Seeman, Sex Differences in Reports of Illness and 
Disability: A Preliminary Test of the "Fixed Role Obligations" Hypothesis. 22 J. HEALTH 
Soc. BEHAV. 174 (1981). 
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that they reflect real differences in health.,,18 Women not only reported 
more illness, they were actually ill more often than men. 
Research indicates there is no one satisfactory explanation for women's 
higher morbidity, but men's higher mortality. One of the most recent 
studies, conducted by Verbrugge in 1989;9 examined five factors: (1) 
biological risks, (2) acquired risks, (3) illness behavior, (4) health-reporting 
symptoms, and (5) prior health care and caretakers. Verbrugge concluded 
of these five, acquired risks (roles and stress) account for women's poorer 
health.2O Additionally, when social factors are taken into account, men 
still have a higher mortality than women.21 This issue needs further 
research. The Council on Ethical and Judicial Affairs recognized the 
contradiction in the existing research, stating: 
Although biological factors account for some differences between 
the sexes in the provision of medical care, these studies indicate 
that nonbiological or nonclinical factors may affect clinical decision 
making. There is not enough data to identify the exact nature of 
nonbiologiCal or nonclinical factors. Nevertheless, the existence of 
these factors is a cause for concern that the medical community 
needs to address.22 
C. FEMALE PHYSICIANS MAy DISPLAY LESS GENDER BIAS THAN MALE 
PHYSICIANS 
In the 1970s, feminists accused physicians of adopting societal attitudes 
which demean women. Feminists charged that physicians had used the 
medical system, through clinical decision making, to reinforce the idea that 
women were helpless, dependent, and less competent than men.23 
Feminists placed the burden of gender bias in health care squarely in the 
laps of physicians. Bernstein and Kane conducted a survey to assess male 
and female physicians' attitudes toward female patients.24 The results 
suggest that physicians perceive women as more emotionally labile than 
men. The more expressive a female was, the more likely the physician was 
to judge the female's complaints as psychosomatic.25 When men behaved 
18. Paul D. Cleary et al., Sex Differences in Medical Care Utilization: An Empirical 
Investigation, 23 J. HEALTII Soc. BEHAV. 106, 115 (1982). 
19. Lois M. Verbrugge, The Twain Meet: Empirical Explanations of Sex Differences in 
Health and Mortality, 30 J. HEALTII Soc. BEHAV. 282 (1989). 
20. Id. 
21. Id. at 295. 
22. Council on Ethical and Judicial Affairs, supra note 3, at 559. 
23. Barbara Bernstein & Robert Kane, Physicians' Attitudes Toward Female Patients, 19 
MEn. CARE 600 (1981) (citing G. COREA, THE HIDDEN MALPRACI1CE (1977». 
24. Bernstein & Kane, supra note 22, at 600. 
25. Id. at 606. 
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emotionally, physicians judged them similarly to expressive women.26 
Bernstein and Kane found no differences in the responses of male and 
female physicians.27 This last finding may be explained by the small 
sample of female physicians. A total of 253 physicians participated; 225 
were men, 28 were women.28 
A recent study by Roter et al. suggests striking differences between 
female and male physicians, regardless of the sex of the patient. 29 In their 
study of 127 physicians (101 men and 26 women), they concluded that 
female physicians devoted more time to the clinical patient visit, talked 
more, and used different communication strategies than males.30 Female 
physicians used patient-centered, positive, relation-building communication 
and provided more biomedical and psychosocial information, regardless of 
the sex of the patient.31 Additionally, both male and female patients 
talked more with female physicians, but women especially benefited from 
exchanges with female physicians.32 While this larger study of female 
physicians may be more reliable than earlier studies, it is difficult to 
compare the two studies because they do not measure the same variables. 
Bernstein and Kane found no differences in responses between male and 
female physicians' attitudes toward female patients, neither did Roter et al. 
The mean age of physicians studied by Bernstein and Kane was forty-one, 
while the mean age studied by Roter was thirty-four. This age difference, 
in addition to the smaller sampling of female physicians by Bernstein and 
Kane, suggests that younger female physicians may have different attitudes 
toward female patients. Additionally, ten years elapsed between studies, 
during which time the medical profession, as well as society, has become 
more sensitive to women's health issues. A follow-up study to Bernstein 
and Kane using a larger sample of female physicians with a broader age 
range might shed light on the hypothesis that female physicians are less 
likely to perceive expressive women as having psychosomatic complaints. 
26. [d. 
27. [d. See also Stephen Colameco et al., Sex Bias in the Assessment of Patient 
Complaints, 16 J. F AM. PRAcr. 1117 (1983 ) (concluding that female physicians as compared 
to male physicians do not hold more favorable attitudes toward female patients). 
28. Bernstein & Kane, supra note 22, at 603. 
29. Debra Roter, Mack Lipkin, Jr., & Audrey Korsgaard, Sex Differences in Patients' and 
Physicians Communication During Primary Care Medical Visits, 29 MED. CARE 1083 
(1991). 
30. [d. at 1091. 
31. [d. at 1092. 
32. [d. See also Nicole Lurie et al., Preventive Care For Women: Does the Sex of the 
Physician Matter?, 329 N. ENG. J. MED. 478 (1993) (concluding women are more likely 
to undergo screening with PAP smears and mammograms if they see female rather than 
male physicians). 
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D. GENDER BIAS AFFECTS OLDER WOMEN DISPROPORTIONATELY 
With the graying of America, the older population has become 
overwhelmingly female. Today women are likely to outlive men by over 
seven years.33 But living longer does not mean living well. In 1986, 
women constituted 71 % of the population entitled to both Medicare and 
Medicaid.34 Older women are not only poorer than older men, but are 
less likely to have private health insurance or other assets. Women have 
"fewer personal financial resources for health care 'than older men, and 
these resources' must be spread out over a longer lifetime. ,,35 
Research suggests gender bias may be more damaging for older 
women, especially given women's higher morbidity rates. A recent study 
by Mutran anq Ferraro suggests that given equal levels of disability and 
overall health status, older men were more likely to be hospitalized than 
older women.36 Mutran and Ferraro propose that physicians' attitudes 
differ for three possible reasons: (1) men may be less able or less likely to 
care for themselves as outpatients, (2) men's self-assessments may be 
perceived as reflective of an actual medical problem (i.e., women are more 
likely to be hypochondriacs), and (3) the decision to hospitalize may be a 
function of the sex of the physician.37 Regardless of the reasons, the fact 
that women are as ill as men, but are not hospitalized as often, constitutes 
discrimination based on gender. Further, this discrimination may preclude 
women's access to in-patient diagnostic procedures which might lead to 
earlier medical interventions. According to Lewis, older women's 
experiences with the health care system have not been positive. Lewis 
states: 
Their chronic diseases are often ignored or undertreated, as 
medicine occupies itself with more acute conditions. Physicians 
tend to belittle their complaints and symptoms by attributing them 
to "post menopausal syndrome," old age, hypochondriasis or other 
neurotic behaviors, "senility," or by over-prescribing tranquilizers 
and other medications in the belief that many physical complaints 
33. Nancy S. Jecker, Age-Based Rationing and Women, 266 JAMA 3012 (1991). 
34. Jecker, supra note 32, at 3012 (citing C. MULLER, HEALTH CARE AND GENDER 
(1991». 
35. Jecker, supra note 32, at 3012. (citing Myrna Lewis, Older Women and Health: An 
Overview, 10 WOMEN'S HEALTH 1, 10-11 (1985». In 1983 the median income for older 
women was $5,599.00 per year compared to $9,766.00 for older men. This placed women 
just $800.00 over the U. S. official poverty level. 
36. Elizabeth Mutran & Kenneth F. Ferraro, Medical Need and Use of Services Among 
Older Men and Women, 43 J. GERONT. S162, S169 (1988). 
37. [d. But see Marjorie Pearson et at., Differences in Quality of Care for Hospitalized 
Elderly Men and Women, 268 JAMA 1883 (1992) (concluding the care received by men and 
women as in-hospital patients is more similar than different). 
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of older women are psychosomatic in origin. . .. There is little 
recognition of the value of older women's lifetime contributions to 
society. Their work is not considered part of the gross national 
product. Their accumulated wisdom, survival skills, range of 
personality, and creativity are seldom acknowledged. It is not 
surprising therefore, that health care workers often reflect the larger 
cultural disregard and even disdain for older women.38 
There is a fear among female medical professionals that in the current 
climate of soaring medical costs, the growing numbers of older patients 
may cause a strong incentive to ration health care based on age.39 Age-
based rationing will disproportionately affect females because there are 
more older women than men, and their relative impoverished state creates 
greater reliance on families and public insurance to meet their medical 
needs. Additionally, age-based rationing may signal to society that older 
citizens have less value and are less deserving than the young. lecker 
states: 
Recognizing the importance of age-based rationing for women 
opens up a broader concern. Namely, inattention to how health 
policies in other areas affect women already has yielded skewed 
health plans and biased assessments of justice. The concern here 
is not that policymakers wantonly denounce women's rights or 
overtly censure women's causes. Rather, women may be prone to 
suffer because health needs vital to them fall prey to neglect or 
indifference. To avert this possibility, we must actively anticipate 
gender issues related to all health policies and give them an alert 
and meticulous hearing. 40 
Gender bias against women is not unique to the older woman, but is 
consistent with patterned inequities felt throughout the life cycle. Hess 
states, "Gender is less a reflection of immutable natural differences than a 
means of dividing people into distinct categories. The gender stratification 
system is a set of power relationships.,,41 As women age, the inequities 
in medical care increase. 
38. Lewis. supra note 34. at 12-13. 
39. lecker. supra note 32. at 3012. 
40. Id. at 3015. 
41. Beth B. Hess. Gender and Aging: The Demographic Parameters, 14 GENERATIONS 
12 (1990). 
. , 
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E. THE MALE MODEL OF HEALTH CARE Is THE NORM 
It is generally accepted that all medical care is based on a male model, 
while care of the female is "other.''''2 Dr. McGoldrick stated in an 
editorial, "[t]ypically, the paradigm patient or research model has been the 
70 kilogram man. Traditional studies on diseases which affect both sexes 
have characteristically used male subjects exclusively, with the results 
extrapolated or generalized, as if to suggest that males are the generic 
humans.,,43 The problem with this male model is that information is 
extrapolated to women with effects ranging from incorrect to lethal. 
Historically, drug companies have conducted clinical trials on new 
drugs using white males exclusively during all stages of testing, and 
physicians have prescribed these drugs to women. Indeed, women are 
prescribed more drugs than men, and suffer more adverse reactions.44 
Evidence in the 1970s and early 1980s suggested that women have 
clinically significant differences in drug metabolism and responsiveness 
throughout the life cycle.45 However, the FDA and drug companies 
refused to use women in clinical trials because (1) testing women subjects 
introduces complexities due to hormonal variations (menstrual cycle, 
pregnancy, menopause), increasing the cost of research, and (2) drug 
companies fear liability from teratogenic effects.46 Underlying these 
theories is the belief that information from testing young white males is 
applicable to women, that men and women are physiologically the same.47 
Examples abound that extrapolation to women of a drug's effects on 
male research subjects is inaccurate and potentially dangerous. Even 
though women have a higher incidence of clinical depression, antidepres-
sants tested only on male subjects can cause hostility and violence in 
women.48 The menstrual cycle can affect antidepressant effects; a 
42. Michelle Harrison, Woman As Other: The Premise of Medicine, 45 J. AM. MED. 
WOMEN'S ASSN. 225 (1990). 
43. Kathryn E. McGoldrick, Women's Health: Is Anatomy Still Destiny?, 45 J. AM. MED. 
WOMEN'S ASSN. 211 (1990). 
44. Jean Hamilton & Barbara Parry, Sex-Related Differences in Clinical Drug Response: 
Implications for Women's Health, 38 1. AM. MED. WOMEN'S ASSN. 126 (1983). 
45. Id. See K. O'Malley et aI., Effect of Age and Sex on Human Drug Metabolism, 3 B. 
MEn. J. 607 (1971); J.F. Giudicelli & J.P. Tillement, Influence of Sex on Drug Kinetics in 
Man, 2 CLIN. PHARMOCOKINET., 157 (1977); S.L. Maiskiewicz et aI., Sex Differences in 
Absorption Kinetics of Sodium Salicylate, 31 CLIN. PHARMAcaL. THER. 30 (1982); G. Fink 
et aI., Sex Difference in Response to Alphaxalone Anaesthesia May Be Estrogen Dependent, 
298 NATURE 270 (1982). 
46. Elizabeth L. Bowles, The Disenfranchisement of Fertile Women in Clinical Trials: 
The Legal Ramifications of and Solutions for Rectifying the Knowledge Gap, 45 V AND. L. 
REv. 877 (1992). Teratogenic effects concern untoward effects of drugs on the developing 
fetus, causing a variety of malfonnations of organ systems. 
47. Id. at 883. 
48. Id. at 888. 
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constant dose may be too high early in the cycle and too low later.49 
Menstrual variations in response to drug therapy also occur with clonidine 
(given for high blood pressure) and Dilantin (given for seizures).5o 
Further, research suggests that oral contraceptive pills and estrogen taken 
for replacement during menopause may influence the metabolism of a wide 
variety of other drugs.51 
Elderly women may be at higher risk for adverse drug reactions than 
younger women. When age bias is added to gender bias in drug therapy, 
the results may be lethal. According to Wolfe, "[a] lot of elderly patients 
have been killed or injured because extrapolations aren't valid.,,52 One-
third of all people over age sixty take five or more drugs simultaneously, 
and women take more drugs than men.53 The U.S. Public Health Service 
reports that older women take sedatives, tranquilizers, hypnotic drugs, drugs 
for hypertension and cardiac conditions, vitamins, analgesics, diuretics, and 
laxatives at two and one-half times the rate of older men.54 The greatest 
danger of taking mUltiple medications involves the synergistic effect of one 
medication when taken with another; that is, drugs have a greater total 
effect than the sum of their individual effects. The aging process compli-
cates the synergistic effect of medications due to delayed absorption, 
metabolism and excretion in the elderly. 55 For these reasons, elderly 
women are more likely to experience adverse drug reactions than are 
others, especially given the paucity of research applicable to women. 
II. Women and Coronary Heart Disease 
According to the Centers for Disease Control in Atlanta, the leading 
cause of death for both men and women in the United States is CHD.56 
Most cases of CHD are due to atherosclerosis, the build-up of lipids in the 
form of plaque which adheres to the walls of the coronary arteries. 57 
CHD can cause angina pectoris, myocardial infarction (heart attack), cardiac 
49. Paul Cotton, Is There Still Too Much Extrapolation From Date On Middle-aged 
White Men?, 263 JAMA 1049 (1990). 
50. Paul Cotton, Examples Abound of Gaps in Medical Knowledge Because of Groups 
Excluded From Scientific Study, 263 JAMA 1051 (1990). 
51. Hamilton & Parry, supra note 43, at 128. 
52. Cotton, supra note 48, at 1050 (quoting Sidney Wolfe, M.D., of the Public Citizens' 
Health Research Group, Washington, D.C.). 
53. Rodin and Ickovics, supra note 12, at 1029. 
54. Id. (citing U.S. Public Health Service, Women's Health: Report of the Health Service 
Task Force on Women's Health Issues (1985». 
55. CHARLOTIE ELIOPOULOS, GERONTOLOGICAL NURSING 347-349 (2d ed. 1987). 
56. Rodin & Ickovics, supra note 12, at 1019 (citing Centers for Disease Control, Trends 
in Lung Cancer Incidence-United States, 1973-1986, 38 MORBIDITY AND MORTALITY 
WEEKLY REPORT 505-506, 511-513 (1989». 
57. CAROL MATTSON PORTH, PATHOPHYSIOLOGY: CONCEPTS OF ALTERED HEALTH 
STATES 277 (2d ed. 1986). 
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arrhythmias (electrical disturbances in heart rhythm), congestive heart 
failure, and sudden death. 58 Risk factors contributing to CHD are 
classified as biological (heredity, sex, race, and age) and behavioral 
(cigarette smoking, high blood pressure, high blood cholesterol levels, and 
diabetes).59 Currently, one of the hottest research topics is coronary heart 
disease in women, evidenced by the NIH's fifteen-year study, the Women's 
Health Initiative.60 Even though CHD is the number one killer of women, 
it strikes them an average of ten years later than men.61 Consequently, 
Cotton states, "[h]eart disease, the number one killer of women, fails to kill 
enough of them fast enough to make its study in females 'feasible. ",62 
Research in CHD excluded women, but the results were extrapolated to 
women because the medical community believed that heart disease was 
principally a "man's disease." Research conducted by Paffenberger in 1975 
and reported as Work Activity and Coronary Heart Mortality used an all-
male group but suggested an "all-people" inclusive population.63 Research 
linking Type A personality with an increase of CHD used 4,000 California 
businessmen, but physicians promptly warned female patients that this may 
be their fate as well. 64 Research indicates that linkage of Type A 
personality to heart disease does not extrapolate to women. In fact, 
working women as a group do not have significantly different rates of CHD 
than housewives.65 
The famous Framingham Study, conducted nearly thirty-five years ago, 
continues to provide much information on CHD. The original cohorts of 
this study consisted of 5,127 persons who, at the baseline exam, were free 
of CHD and are reexamined biennially. In 1986, a follow-up on the 
Framingham Study by Lerner and Kannel suggested that before a 
myocardial infarction, women with CHD presented angina more often than 
men.66 However, after a myocardial infarction, women's prognosis for 
58. Id. at 277. 
59. AMERICAN HEART AsSOCIATION, HEALTHCARE PROVIDER'S MANUAL FOR BASIC LIFE 
SUPPORT 17, 18 (1990). 
60. Bernadine Healy, Women's Health, Public Welfare, 266 JAMA 566 (1991). 
61. Cotton, supra note 49, at 1055. 
62. Cotton, supra note 48, at 1049. 
63. Lila A. Wallis & Perri Klass, Toward Improving Women's Health Care, 45 J. AM. 
MED. WOMEN'S ASSN. 219 (citing Paffenberger et al, Work Activity and Coronary Heart 
Mortality, 292 N. ENG. J. MED. 545 (1975». 
64. Id. at 219 (citing Rosenman et al., Coronary Heart Disease in the Western 
Collaborative Group Study: Final Follow-up Experience of 8 112 Years, 233 JAMA 872 
(1976) (Type A personality is marked by aggression, high motivation, and anger». 
65. Wallis & Klass, supra note 62, at 219 (citing S. O. Haynes & M. Feinleib, Women, 
Work and Coronary Disease: Prospective Findings From the Framingham Heart Study, 70 
AM. J. PuBLIC HEALTH 133 (1980». 
66. Debra J. Lerner & William B. Kannel, Patterns of Coronary Heart Disease Morbidity 
and Mortality In the Sexes: a 26-Year Follow-up of the Framingham Population, 111 AM. 
HEART J. 383 (1986). But see Howard Dittrich et al., Acute Myocardial Infarction in 
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survival and morbidity (development of post-infarction angina, congestive 
heart failure, and reinfarction) were worse than for men.67 Wenger 
criticized Lerner and Kannel's conclusion that pre-infarction angina was 
essentially a benign problem. Wenger stated: 
Clearly the favorable prognosis of women with "angina" in 
Framingham reflected a substantial prevalence of women without 
coronary heart disease; this flawed myth of better tolerance of 
angina fostered less attention to women with this, less concern with 
their preventive care and coronary risk modification, and probably 
led to inappropriate decisions about objective testing .... The 
opportunity both for preventive therapies and for earlier and safer 
myocardial revascularization may have been missed, owing to 
misinterpretation of the chest pain data.68 
A. DIAGNOSIS AND TREATMENT OF ANGINA IN WOMEN 
Angina,69 the chest pain associated with CHD, can be very difficult 
to diagnose because the symptoms mimic other conditions. Porth states, 
"in some persons, the arm or shoulder pain may be confused with arthritis; 
in others, the epigastric pain is thought to result from indigestion.,,7o 
Physiologically, male and female hearts are identical - CHD and its 
symptomatology are identical. No research to date suggests women's 
angina is different in character or presentation than angina in men. 
However, studies show that the diagnosis and treatment of chest pain 
differs by gender. 71 
In a recent follow-up study to the original Mayo Clinic study, Orencia 
et a!. searched the medical records of 1,000 participants diagnosed with 
angina or heart attack between 1960 and 1979 to investigate the effect of 
Women: Influence of Gender on Mortality and Prognostic Variables, 62 AM. J. CARDIOL. 
1 (1988) (suggesting there is no gender difference in mortality after adjusting for age). 
67. Lerner & Kannel, supra note 65, at 384-85. But see Fiebach et aI., Differences 
Between Women and in Survival After Myocardial Infarction: Biology or Methodology?, 263 
JAMA 1092 (1990) (concluding higher mortality rates of women following MI are related 
to known risk factors, and gender should not be considered an independent risk factor). 
68. Nanette K. Wenger, Gender, Coronary Artery Disease, and Coronary Bypass Surgery, 
112 ANN. INT. MED. 557 (1990). 
69. Angina in this article refers to angina pectoris which means heart pain caused by an 
insufficient supply of blood to the heart, a result of CHD. Classic angina pectoris presents 
as a severe, crushing pain in the middle of the chest and may be accompanied by anxiety, 
shortness of breath, sweating, and radiation of pain down the left arm, up the neck to the 
jaw, or through to the back. TABER'S CYCLOPEDIC MEDICAL DICTIONARY 82-83 (13th ed. 
1977). 
70. PORTH, supra note 56, at 279. 
71. Verbrugge & Steiner, supra note 8, at 628. 
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gender on long-term outcome.72 Research revealed that angina in women 
is less likely to portend either a future myocardial infarction or sudden 
unexpected death than angina in men. More importantly, treatment after 
initial diagnosis of angina markedly differed between men and women. 
Physicians prescribed nitrates (vasodilators which increase oxygen supply 
to the heart muscle) and anticoagulation (blood-thinning) therapy more 
often to men and prescribed diuretics (water pills) more often to women.73 
Additionally, Orencia states, "[t]here is some evidence that the women in 
this study were evaluated and treated less aggressively than the men.,,74 
Orencia et al. failed to address the issue of what would have constituted 
appropriate care. Dr. Yawn, one of Orencia's colleagues in this study, 
stated, "[o]ur findings suggest that if women are diagnosed earlier, they can 
do as well as the men. Maybe in those previous studies the women were 
not treated aggressively enough. We need to look back at those studies to 
see what happened before the heart attack. ,,75 
B. MEDICAL AND SURGICAL INTERVENTIONS FOR CHD 
Once a patient with known CHD is admitted to a hospital with the 
diagnosis of unstable angina, which may signal an impending myocardial 
infarction (death of a portion of the myocardium) or a myocardial infarction 
in progress, several treatment modalities are available. If the patient has 
not yet had a myocardial infarction, he or she may receive an angioplasty, 
an invasive procedure in which a balloon on the end of a catheter is 
threaded into the coronary arteries and inftated in order to open up the 
narrowed area.76 If a patient arrives at the hospital with a myocardial 
infarction in progress, he or she may be a candidate for thrombolysis, or 
administration of powerful drugs which act directly on the clot occluding 
the coronary artery to dissolve it.77 If the patient arrives at the hospital 
either before, during, or after a myocardial infarction with severe multiple 
coronary artery disease (more than one coronary artery involved), he or she 
may be eligible for a coronary artery bypass graft (CABO), a surgical 
intervention which removes areas of diseased coronary arteries and grafts 
new vessels in their place.78 While all of these treatment modalities are 
72. Anthony Orencia et aI., Effect of Gender On Long-term Outcome of Angina Pectoris 
and Myocardial Infarction/Sudden Unexpected Death, 266 JAMA 2392 (1993). 
73. Id. at 2392. 
74. Angina Update: Gender Differences, 18 HEALTHFACTS 2 (1993). 
75. Id. at 2. 
76. STEVEN A. SCHROEDER ET AL., CURRENT MEDICAL DIAGNOSIS AND TREATMENT 264 
(30th ed. 1991). 
77. Id. at 268 (The minimum time for treatment after onset of symptoms differs according 
to the procedure or medication administered). 
78. Id. at 263-64. 
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not without significant risk, the risk of dying from a myocardial infarction 
is also great. 79 
Even after diagnosis of CHD, women may not have equal access to 
treatment modalities. This lack of access may affect the outcome (mortality 
or morbidity) disproportionately. In 1991, a study by Ayanian and Epstein 
suggested that women who are hospitalized for CHD undergo fewer major 
diagnostic and therapeutic procedures than men.80 Their results showed 
that men are more likely than women to undergo coronary angiography 
(diagnostic dye study of the vasculature of the heart), and revascularization 
procedures (angioplasty and CABO) for known or suspected CHD, even 
after controlling for clinical and demographic variables.81 Researchers 
state, "[W]omen may not have equivalent access to these procedures at a 
time when the incidence of coronary heart disease among women is 
increasing.,,82 Ayanian and Epstein's research brought mixed reviews. 
While one group of researchers questioned their findings,83 another group 
not only supported Ayanian and Epstein's research, but indicated that there 
appeared to be no regional differences with respect to gender access and 
treatment modalities. 84 
A study published a year later confirmed Ayanian and Epstein's 
conclusion that all three treatment modalities (thrombolytic therapy, 
coronary angioplasty, and CABO) were used less often in women 
hospitalized for acute myocardial infarction. 85 Researchers suggested the 
gender disparity may be related to confounding factors such as advanced 
age, and an increase in diabetes mellitus in women, but urged more 
research in the decision-making process for referral for women.86 
In 1993, researchers studying survival rates after a myocardial 
infarction suggested women who follow the treatment regimen of their 
79. AMERICAN HEART ASSOCIATION, TExTBOOK OF ADVANCED CARDIAC LIFE SUPPORT 
2 (1987). In 1987, approximately 1.5 million people in the United States sustained a 
myocardial infarction. Of those, 540,000 (36%) died. Of those who died, over one-half or 
350,000, died before reaching the hospital; most of these deaths occurred within two hours 
of the onset of symptoms. Id. 
80. John Z. Ayanian & Arnold M. Epstein, Differences In the Use of Procedures Between 
Women and Men Hospitalized For Coronary Heart Disease, 325 N. ENG. J. MED. 221 
(1991). 
81. Id. at 222-23. 
82. Id. at 225. 
83. Roy Poses et al., Is There Sex Bias In the Management of Coronary Artery Disease? 
326 N. ENG. J. MED. 570 (1992). 
84. David Foster et al., Is There Sex Bias In the Management of Coronary Artery 
Disease? 326 N. ENG. 1. MED. 570, 571 (1992). 
85. Charles Maynard et al., Gender Differences in the Treatment and Outcome of Acute 
Myocardial Infarction, 152 ARCH. INTERN. MED. 972 (1992). 
86. Id. at 976. 
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physicians have a lower mortality than women who do not comply.87 
However, other research suggests this is true for men as well. 88 Further, 
noncompliance places "blame" for mortality squarely on the patient. 
Conclusions drawn from this study are limited because women were 
excluded from the substudy which surveyed four important variables -
levels of life stress, social isolation, depression, and Type A behavior. 89 
Studies involving only one treatment modality as a variable seem to suggest 
gender bias as often as research of multiple treatment modalities. 
1. Fewer Women Offered Thrombolytic Therapy Than Men 
Pfeffer et al. suggest that fewer women received thrombolytic therapy 
because they were classified as ineligible more often than men. 90 
Thrombolytic therapy involves the early introduction of intravenous drugs 
which dissolve blood clots restricting blood flow through major vessels. 
Thrombolytic therapy instituted in the early stages of myocardial infarction 
decreases or at least limits the amount of myocardial tissue death.91 This 
study indicates that when thrombolytic therapy is not offered as a treatment 
modality for older patients and patients with prior myocardial infarction, 
impaired functional status, diabetes, and neurological diseases, as well as 
patients who are unemployed. The net result is that women are excluded 
more often than men.92 Researchers state, "[e]ven though thrombolytic 
therapy is of proven benefit in increasing survival following myocardial 
infarction, the majority of patients currently do not receive this therapy, and 
these patients are at higher risk for adverse events.,,93 However, Pfeffer 
et al. stop short of suggesting this difference in· access is due to gender 
bias. 
2. Higher Mortality For Women Receiving Angioplasty 
A current study of mortality rates for angioplasty suggests a higher 
mortality for women than for men. Bell et al. studied the in-hospital death 
rates for patients receiving angioplasty and concluded the death rate was 
2.7% for men and 4.2% for women.94 Angioplasty is an adjunct or 
87. E. John Gallagher et al., The Relationship of Treatment Adherence to the Risk of 
Death After Myocardial Infarction in Women, 270 JAMA 742 (1993). 
88. Id. at 741 (citing Coronary Drug Project Research Group, Influence of Adherence to 
Treatment and Response of Cholesterol on Mortality in the Coronary Drug Project, 303 N. 
ENG. J. MED. 1038-1041 (1980». 
89. Gallagher, supra note 86, at 745. 
90. Marc A. Pfeffer et al., Selection Bias in the Use of Thrombolytic Therapy in Acute 
Myocardial Infarction, 266 JAMA 528, 529 (1991). 
91. SCHROEDER, supra note 75, at 268. 
92. Pfeffer, supra note 89, at 531. 
93. Id. 
94. Malcolm R. Bell et al., The Changing in Hospital Mortality of Women Undergoing 
Percutaneous Transluminal Coronary Angioplasty, 269 JAMA 2091 (1993). 
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alternate therapy to thrombolysis used if thryombolysis fails or if the 
required time for administration of thrombolytics has expired.9S Bell's 
study also indicates women who died were significantly older, and had 
more severe angina, heart failure, diabetes, high blood cholesterol and high 
blood pressure than men.96 Researchers attributed women's higher 
mortality to advanced age of the women tested (four to ten years older than 
the men) and the severity of the underlying heart disease. They concluded 
these factors, and not gender, accounted for the differences in mortality 
rates. 97 
3. Higher Mortality For Women Receiving Coronary Artery Bypass 
Grafts 
Several studies indicate a higher mortality rate for women who undergo 
coronary artery bypass grafting (CABO) than for men, but each proposes 
a different reason for the discrepancy. CABO is a major open-heart 
surgical procedure which requires replacing diseased and/or occluded 
coronary arteries with healthy veins harvested from the leg of the patient. 
Surgeons perform CABO for cardiac patients who exhibit more severe 
symptoms of CHD, especially following a myocardial infarction or several 
failed angioplasties (reocclusion of artery).98 Researchers from the 
Coronary Artery Surgery Study (CASS) suggest the smaller size and stature 
of women may pose technical problems which increase women's mortali-
ty.99 Perhaps these "technical problems" are a form of gender bias as 
well. If the surgical instruments are not sized appropriately for a women's 
smaller anatomy, it is understandable that there might be technical 
problems. Dr. Yawn, referring to studies showing higher mortality in 
women who undergo angioplasty which involves threading of a catheter 
sized for males states, "One of the things which fascinates me about the 
reaction [from male doctors] to such a finding is, 'Oee, the catheter is too 
big for women's smaller arteries.' Well, why didn't they think of using a 
smaller catheter to begin with?"loo This male-centered model may apply 
to surgical interventions as well; however, the "technical difficulties" have 
received no attention in research. 
95. SCHROEDER, supra note 75, at 269. 
96. Bell, supra note 93, at 2091. 
97. Id. 
98. SCHROEDER, supra note 75, at 263-64. 
99. Stephen S. Kahn et al., Increased Mortality of Women in Coronary Artery Bypass 
Surgery: Evidence for Referral Bias, 112 ANN. INT. MED. 561 (1990) (citing D. Fisher et 
al., Association of Sex, Physical Size, and Operative Mortality After Coronary Artery Bypass 
in the Coronary Artery Surgery Study (CASS), 84 J. THORAC. CARDIOVASC. SURG. 334-41 
(1982». 
100. HEALTHFACfS, supra note 73, at 3. 
I. 
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Kahn et al. documented a higher in-hospital mortality for women 
undergoing CABG, but attributed this to differences in preoperative status 
and age (women were older, had a higher incidence of unstable angina, and 
had congestive heart failure). 101 Further, Kahn observed women are 
referred for CABG later in the course of their disease than men, and this 
may increase their intraoperative mortality. Therefore, evidence suggests 
a "referral bias" and not a treatment bias. 102 
Tobin et al. suggested a gender bias against considering women for 
CABG and found men ten times more likely than women to be referred for 
cardiac catheterization (diagnostic dye study) following a positive nuclear 
exercise test (diagnostic exercise testing). 103 These tests are essential to 
a diagnosis which would result in CABG. 
The evidence from the above medical research suggests women are 
referred later than men for all diagnostic, medical and surgical interven-
tions. It does not matter what rationale is given to explain this phenome-
non. The result is that women are older and sicker by the time clinicians 
grant access to life-saving procedures, and this delay results in higher 
mortality for women. The question researchers need to answer is why 
women are consistently denied earlier access. Early access would mean 
women would undergo dangerous invasive procedures at a younger age 
with less advanced disease and fewer other related disorders (congestive 
heart failure, diabetes, unstable angina) which tend to occur more often in 
older women. Wenger states, "[ c ]learly, if deferral of evaluation and 
intervention results in these procedures being undertaken at an older age, 
often with a more adverse symptomatic status precipitating evaluation and 
intervention, this deferral must be considered as a variable contributing to 
unfavorable outcomes."I04 Certainly, death is considered an "unfavorable 
outcome." Reports of higher mortality in women undergoing treatment 
interventions further influenced physicians to refer women more infre-
quently for invasive procedures. 105 Instead of warning women not to 
have these procedures, physicians should interpret the data as indicating 
that procedures should be done, and done at an earlier stage of disease. 
III. Legal Ramifications of Gender Bias in Health Care 
Research examining gender bias in health care, specifically in the area 
of women and CHD, fails to address the origin or cause of gender bias. 
However, it is clear that women do not have equal access to life-saving 
101. Kahn, supra note 98, at 561. 
102. [d. at 566. 
103. Jonathan N. Tobin et aI., Sex Bias in Considering Coronary Bypass Surgery, 107 
ANN. INT. MED. 19 (1987). 
104. Wenger, supra note 67, at 558. 
105. [d. at 557. 
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interventions such as thrombolysis, angioplasty, and CABO at the same 
stage of coronary disease as men. Later access and intervention result in 
higher mortality for women. Hospitals, and physicians who perform these 
interventions in hospitals, are making decisions regarding access based on 
gender, rather than on clearly articulated medical facts. This constitutes 
discrimination based on gender. 
Almost all public and private healthcare facilites in the United States 
receive federal assistance, in the form of Medicaid and Medicare, which 
subjects these facilites to Title VI.I06 Congress enacted Title VI as part 
of the 1964 Civil Rights Act107 partly to prevent the use of federal funds 
by healthcare facilities who openly discriminated on the basis of race. 
Suprisingly, though, Title VI does not prohibit discrimination on the basis 
of sex. The relevant section of Title VI provides: 
No person in the United States shall, on the ground of race, color, 
or national origin, be excluded from participation in, be denied the 
benefits of, or be subjected to discrimination under any program or 
activity receiving Federal financial assistance. lOS 
To highlight this omission, compare Title VII of the Civil Rights Act of 
1964,109 which provides: 
It shall be unlawful employment practice for an employer to fail or 
refuse to hire or to discharge any individiual, or otherwise to 
discriminate against any individual with respect to his compensa-
tion, terms, conditions, or privileges of employment, because of 
such individual's race, color, religion, sex, or national origin . 
110 
One must query if the omission of discrimination based on sex in Title VI 
was intentional or merely a congressional oversight. 
There is another important difference between Title VI and Title Vll. 
Title VII's prohibition against employment discrimination is authorized by 
Congress' power under the commerce clause to regulate interstate 
commerce. lll Alternately, Title VI is authorized by Congress' power 
106. W. Jones & M. Rice, Public Policy Compliance/Enforcement and Black American 
Health: Title VI of the Civil Rights Act of 1964, in HEALTH CARE ISSUES IN BLACK 
AMERICA 99, 100 (W. Jones & M. Rice eds., 1987). 
107. 42 U.S.C. §§ 2000d et seq. (1982). Title VI regulates any "recipient" of federal 
funds which includes "any public or private agency, institution, or organization." 45 C.F.R. 
§ 80.13(i) (1989). 
108. 42 U.S.C. § 2000d (1982) (Medicaid and Medicare are considered federal financial 
assistance). 
109. 42 U.S.C. §§ 2000e et seq. (as amended by the Civil Rights Act of 1991). 
110. 42 U.S.C. § 2000e-2 (1991) (emphasis added). 
111. United Steelworkers v. Weber, 443 U.S. 193,206 n.6 (1979) . 
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under the spending clause to regulate the availability of federal funds. 1I2 
Unlike Title VII, which imposes an obligation, Title VI offers an option: 
"Accept federal money and do not discriminate, or discriminate and do not 
get federal money."I13 
Although Title VII cases differ factually from Title VI cases, courts 
analyze Title VI cases using Title VII theories of discrimination, i.e., 
disparate treatment (intentional) and disparate impact (unintentional).114 
The Court in Alexander v. Choate 11 5 (intepreting Guardiansll6) held 
that Title VI requires intentional discrimination, but Title VI's implement-
ing regulations that prohibit unintentional discrimination are valid. The 
disparate impact doctrine used in Title VII gender discrimination cases may 
be extrapolated to healthcare law. Under the disparate impact doctrine, a 
woman can establish discrimination by demonstating that women as a class 
are more severely affected than men by a facially neutral practice or 
policy. 117 Disparate impact plaintiffs do not need to show intentional 
discrimination based on sex. Rather, disparate impact cases are concerned 
with impact, or outcome, and focus on what actually happened rather than 
the intended effect. Courts do not scrutinize statutory cases using 
intermediate scrutiny. However, they are more intolerant of racial 
differentations than sexual differentations. 1I8 Applying the disparate 
impact doctrine to the unequal access to treatment of women with CHD, it 
would not be difficult to prove with statistics from the research discussed 
above that women's outcomes from CHD differ dramatically because of 
delayed access to treatment, evidenced by women's higher mortality. It 
would be difficult for a defendant to dispute the research in this area. 119 
Presently, Title VI can not be used as the basis an action for gender 
discrimination in health care. Any Title VI gender discrimination claim 
will prove futile until Congress amends Title VI to include sex as a 
protected class. Other federal statutes prohibit hospitals from discriminat-
ing on the basis of race, sex, national origin, physical handicap, or age. 
112. Guardian& Ass'n v. Civil Servo Comm'n, 463 U.S. 582, 599 (1983). 
113. Sidney D. Watson, Reinvigorating Title VI: Defending Health Care Discrimina-
tion-It Shouldn't Be So Easy, 58 FORDHAM L. REv. 939, 944 (1990) (quoting Rep. 
Lindsey, 110 CONGo REc. 1542 (1964». 
114. See Bryan V. Koch, 627 F.2d 612 (2d Cir. 1980). See also NAACP V. Medical Ctr., 
Inc., 657 F.2d 1322 (3d Cir. 1981). 
115. Alexander V. Choate, 469 U.S. 287, 294 (1985). 
116. Guardians Ass'n V. Civil Servo Comm'n, 463 U.S. 582 (1983). 
117. Christine A. Littleton, Reconstructing Sexual Equality, 75 CAL. L. REv. 1279 (1987) 
(The disparate impact doctrine has been used successfully in Title vn gender discrimination 
in the workplace). 
118. Ruth Colker, The Anti-Subordination Principal: Applications, 3 WIS. WOMEN'S L.l. 
59 (1987). 
119. See Part IV, infra. 
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Federal law prohibits hospitals which enjoy tax exempt statusl20 or have 
received construction grants under the Hill-Burton Ace21 from discrimi-
nating. Similarly, state laws may also prohibit discrimination in places of 
public accommodation. 122 The Joint Commission on Accreditation of 
Healthcare Organizations (JCAH) requires "impartial access to treatment 
. . . regardless of race, creed, sex, national origin, or sources of payment for 
care." 123 Medicare automatically deems any hospital with JCAHO 
(fonnerly JCAH) accreditation to be fit for Medicare participation. 
Therefore, Medicare accepts JCAHO's non-discrimination standards in 
additon to federal standards for Medicare. 124 
Gender discrimination in health care may be actionable under the Equal 
Protection Clause of the Fourteenth Amendment. The State Action 
Doctrine arguably applies to those situations where patients are denied 
access to procedures perfonned in hospitals which receive state and federal 
funding via Medicaid and Medicare. States, or state actors, who discrimi-
nate on the basis of gender violate the Fourteenth Amendment. The State 
Action Doctrine is available to to a private party seeking damages and 
other remedies when the state violates that party's civil rights under the 
Equal Protection Clause. l25 When a state is significantly involved in 
statutorily authorized private conduct, such as administering Medicare and 
Medicaid funding for private and public hospitals, then the state's conduct 
may constitute "state action.,,126 If a sufficient nexus exists between the 
hospital's conduct and the action of the federal government, and federally 
protected constitutional rights are at stake, the State Action Doctrine 
applies. 127 In order to show a sufficient nexus, the complaining party 
must show that (1) the state is so entertwined with regulating private 
conduct as to constitute state activity; (2) the state delegated what has 
120. Rev. Rul. 69-545, 1969-2 C.B. 
121. The Hill-Burton Act, 42 U.S.C. § 291 (1994), enacted post WWII provided funds for 
hospital construction to address the shortage of medical facilities. Hospitals receiving Hill-
Burton funds must provide a certain amount of uncompensated medical care and community 
service. See also Kenneth R. Wing, The Community Service Obligation of Hill-Burton 
Health Facilities, 23 B.C. L. REv. 577 (1982). 
122. In California, The Unruh Civil Rights Act provides in part, "All persons within the 
jurisdiction of this state are free and equal, and no matter what their sex, race, color, 
religion, ancestory, national origin or disability are entitled to the full and equal 
accommodations, advantages, facilities, priviliges, or services in all business establishments 
of every kind whatsoever." Cal. Civil Code § 51 (Deering 1995). 
123. MARK A. HALL & IRA MARK ELLMAN, HEALTH CARE LAW AND Enncs 81-82 
(1990) (quoting JCAH, ACCREDITATION MANUAL FOR HOSPITALS (1990}). 
124. Cospito v. Heckler, 742 F.2d 72 (3d Cir. 1984) (holding that "deeming" is 
constitutional). 
125. Civil Rights Cases, 109 U.S. 3 (1883). 
126. [d. 
127. Burton v. Wilmington Parking Auth., 360 U.S. 252 (1961) (state action existed where 
there was a partnership or symbiotic relationship between the state and a private party). 
I. 
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traditionally been a state function to a private party (hospitals); and (3) the 
state was the source of authority for private action. 128 At first blush, one 
might assume a sufficient nexus exists between hospitals who receive 
federal and state funds and the state to establish state action. However, 
courts have refused to find a significant nexus between the state and a 
hospital's receipt of Medicare, Medicaid,129 or Hill-Burton funds.130 
In an Equal Protection challenge of gender discrimination in health 
care, the defendant hospital or physician must justify the offending policy 
under the intermediate scrutiny standard applied to gender-based classifica-
tions.131 In Craig v. Boren, the Court first articulated a formal standard 
of review for gender-based classifications, stating, "[p ]revious cases 
establish that classifications by gender must serve important governmental 
objectives and must be substantially related to achievement of those 
objectives." 132 
Defendant physicians could argue that they may not know a woman's 
symptoms are as severe or indicative of needed intervention as a man's 
symptoms because the same symptoms of CHD do not appear to portend 
equal outcomes for men and women; that is, if a woman presents with 
angina, she has a lower morbidity from CHD than a man. The overriding 
governmental objective in delaying care may be articulated as concern for 
providing expensive, "needless" interventions unwarranted by the symptoms 
presented by women. If monetary concerns are the "important governmen-
tal objective", this argument fails the second part of the Boren test - "it 
must be substantially related to achieve those objectives.,,133 It is far 
more expensive to provide healthcare for older women with multiple 
disease processes (diabetes, high blood pressure, high blood cholesterol 
levels, congestive heart failure) who will suffer a higher mortality with any 
CHD intervention than it is to medically intervene at an earlier stage of 
CHD. 
Presently, without congressional amendment to Title VI and concurrent 
changes in the courts' unwillingness to find state action in hospitals' receipt 
of federal funds, litigation on the issue of gender discrimination in 
healthcare will be unsuccessful, whether the issue is litigated on a 
constitutional or statutory basis. 
128. [d. 
129. Parvis Modaber v. Culpepper Memorial Hosp., Inc., 674 F.2d 1023, 1026 (4th Cir. 
1982). 
130. [d. at 1026. 
131. Craig v. Boren, 429 U.S. 190 (1976). 
132. [d. at 197. 
133. [d. 
",err . , , 
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IV. Solutions to Gender Bias 
Litigation to address discrimination is not only expensive, but may take 
years to effect change in laws and attitudes. l34 Litigation can successfully 
be employed to raise the consciousness of the public and to highlight this 
area of discrimination. A more immediate solution involves prevention of 
gender discrimination. 
A. NATIONAL INSTITUTE OF HEALTH (NIH) FuNDING FOR WOMEN'S 
HEALTHCARE ISSUES 
A study by the Public Health Service in 1985 indicated that a dearth 
of medical data on women limited understanding of women's health care 
needs. NIH responded two years later by promising to encourage the use 
of women in clinical studies. Further, NIH promised to require grant 
applicants to explain why they excluded women from proposed research. 
However, as of June 1990, nearly three years after this promise, the 
General Accounting Office (GAO) reported NIH had made very little 
progress toward this end. 135 NIH National Heart, Lung, and Blood 
Institute Deputy Director Peter L. Frommer, M.D. says, "[w]e try to live by 
the precept [of holding grant recipients responsible for including women, 
or explaining why they exclude them].,,136 But Dr. Frommer admitted he 
was unable to answer whether trials using women have been turned down, 
and challenges critics, "[i]f people are contending that we have been 
derelict in [funding] studies with inappropriate bias, they should identify 
our errors.,,137 Dr. Frommer states the burden inaccurately. By NIH's 
own policy, it is incumbent upon NIH to prove to GAO that they have 
complied with their own rules and regulations, and not upon the general 
public to prove NIH failed to comply. 
It is encouraging to see that in recent years NIH has taken their 
promise more seriously. In 1990, following the unfavorable GAO report, 
NIH opened the Post-Menopausal Estrogen Progestin Intervention Trial 
(PEPO, its first large-scale clinical trial evaluating over 800 post-menopaus-
al women for heart disease risk factors. 138 In 1991, the new director of 
NIH, Bernadine Healy, hailed the Women's Health Initiative (of which 
PEPI is a part), as the "most definitive, far-reaching study of women's 
134. See Brown v. Board of Education of Topeka, Shawnee County, Kan., 347 U.S. 489 
(1955) (ordering courts to act "with all deliberate speed", but by 1964 only one third of 
southern school districts had desegregated). 
135. Council on Ethical and Judicial Affairs, supra note 3. 
136. Cotton, supra note 48, at 1049 (quoting Dr. Peter L. Frommer, Deputy Director, 
National Heart, Lung, and Blood Institute, NIH, Bethesda, MD.). 
137. [d. 
138. McGoldrick, supra note 42, at 211. 
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health ever undertaken . . . [to] examine heart disease and stroke, cancer, 
and osteoporosis - the major causes of death, disability, and frailty in 
women of all races and socioeconomic strata.,,139 However, a recent 
newspaper account suggests the project is flawed, according to the Institute 
of Medicine, a congressionally chartered review panel. 140 The panel 
stated, "much of the information could be obtained in better designed, 
smaller, more focused studies that could have a greater chance of success 
and probably be less costly.,,141 So far the project involves 160,()()() post-
menopausal women (for the entire Women's Health Initiative) and its cost 
is expected to exceed $625,000,000 over a fourteen year period. It is 
possible that the largest single research study ever funded by NIH might 
fail due to its design, making it difficult to draw statistically valid 
conclusions. While NIH's efforts need to be applauded, a failed study of 
this magnitude may cause researchers to avoid women's health issues in the 
future. It is essential that NIH carefully review the panel's recommenda-
tions and modify the design in the study's early stages before more money 
and time are wasted on "flawed" design. Throwing money at a problem 
rarely creates solutions. Women want and need answers which statistically 
valid research can provide. 
B. MEDICAL SCHOOLS - CHANGE THE MALE-CENTERED MODEL 
The second possible solution to gender bias is to attack the problem at 
its source by altering the manner in which medical schools use the male-
centered model of health care, and exclude women's health. Drs. Wallis 
and Klass state, "when students are taught about women's health only in 
terms of disorders of the breast, uterus, cervix, and vagina, then - for 
some doctors - the very state of being female almost comes to imply 
pathology, while the norm is so eminently male."142 Dr. McGoldrick 
identifies the source of the male model of health care as originating in 
medical school. 143 
There are two ways to alter this male-centered model. First, change the 
medical school curricula to include two models - one for males and one 
for females. Second, encourage more females to become physicians. 
Bernadine Healy, Director of NIH, states: 
Progress in addressing the gender discrepancies that have been 
documented cannot depend alone on swelling the ranks of female 
researchers and physicians . ... Here, more may be needed. 
139. Healy, supra note 59, at 567. 
140. Earl Lane, Panel Criticizes 14-Year Study on Women's Health, WEST COUNTY TIMEs 
(Contra Costa County, CA), Nov. 2, 1993, at B2. 
141. [d. 
142. Wallis & Klass, supra note 62, at 220. 
143. McGoldrick, supra note 42, at 211. 
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Namely, we must train all medical students, male and female, to 
understand the biological differences between the sexes, to take the 
time to listen to their patients, to respect their patients' concerns 
and anxieties, and, most of all - as so many women have 
consistently written to me - to take them seriously. 144 
When medical schools teach both the male and female model for health 
care, women's health issues will no longer be an oddity, and physicians 
will seriously consider women's health concerns. 
C. FEMALE MEDICAL SPECIALTY 
When the American Medical Women's Association (AMWA) convened 
in Philadelphia in 1990 to discuss a proposed curriculum for a women's 
health specialty, a fierce "turf' battle began. The AMWA recognized the 
need for a women's health specialty to address the female patient's entire 
medical needs, which include internal medicine, psychiatry, nutrition, 
orthopedics, urology, preventive medicine, as well as OB/GYN services -
all provided by one physician. However, the AMWA encountered strong 
opposition from the American Academy of Family Physicians, American 
College of Obstetricians and Gynecologists, and even the American College 
of Physicians. 145 All of these organizations argued that they provided 
health care addressing all health concerns of women; however, the AMW A 
disagreed. 
The Women's Movement empowered women and encouraged them to 
take control over their own bodies. Power resided in lay workers who 
formed hundreds of women-run alternative health centers. This message 
of empowerment filtered out to physicians, and the AMWA responded. l46 
A women's health specialty, as proposed by the AMWA embodies a 
multidisciplinary approach to health in order to treat the whole person, not 
just parts or organs in isolation. "The concept of women's health has been 
shaped by consumer activism. It implies a commitment to prevention, 
patient education, and information exchange. Women... expect to be 
partners in health care and practitioners who serve these women will do 
well to embrace this perspective." 147 
Conclusion 
Evidence suggests a gender bias exists for women in health care, 
especially for older women with CHD. Researchers frequently argue over 
144. Healy, supra note 59, at 567. 
145. Wallis & Klass, supra note 62, at 220-21. 
146. Johnson & Dawson, supra note 7, at 222. 
147. Id. at 224. 
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the causes for this bias, but most accept its existence. It is not necessarily 
as important to discover the cause of gender bias as it is to seek solutions. 
Gender bias in health care may be a litigatable issue. However, there 
are no cases on point. More immediate solutions include supporting 
legislation which directly alters gender bias. In addition, women should 
hold NIH accountable and insist they follow the mandate to include more 
women in clinical drug trials and research so that medical decisions for 
women are based on data relevant to women. Female consumers and 
physicians need to encourage medical school curricula which presents both 
a male and female model of health care. Finally, women need to support 
the AMW P: s proposal for a mUltidisciplinary health specialty. 
It is not enough for women to wait for professionals to make changes. 
"Women constitute 52% of the popUlation and account for about 70% of 
all health provider/consumer interactions, yet they represent only a small 
fraction of the decision-making groups in medical education, training, 
practice, and policy.,,148 Women have power and voice which can be 
exercised at five levels - as voters, taxpayers, supporters of women's 
organizations, supporters of women in academia, and as partners in health 
care with physicians - for changes which can occur. Women must insist 
upon change. 
148. Wallis & Klass, supra note 62, at 220. 
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